pc semaglutide Compounded SEMAGLUTIDE 5MG - Lyophilized

Coetzee and me, develop personalized nutritional protocols

In the SURMOUNT-1 clinical trial, patients on the highest dose of tirzepatide lost an average of 22.5% of their body weight over 72 weeks the highest average weight loss ever recorded in a Phase 3 obesity trial

While this additive effect might seem beneficial, unmonitored combination therapy can lead to dangerously low blood glucose levels

GLP-1 therapy shifts patients out of both extremes

This makes GLP-1 a powerful tool in the quest for better health and improved quality of life, offering hope and optimism for those on the journey to managing obesity-related concerns.

It isn't FDA-approved yet, but you can buy it for experimental purposes